Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
The cartels run the majority of Mexico. If they think it will save them they’ll just use it. The government will put up a good front to make it look scientific. The only people that will know is NP through product sales. It will appear “peculiar”. Many will deny this... doesn’t matter.
Curious that NIH blocked leronlimab. That only adds to the BigPharm conspiracy theories.
As do I, and I will when the company gives something defensible.
As I would.... the BS PRs are great for flippers but let’s see some meat (pictures) and then we’ll get somewhere.
Good lord what a ripoff.
Agreed. Those buying are waiting for better prices and that includes the big fish. Those shorting are burnt and are waiting for NP to screw up a PR or for a negative catalyst. The shorts are also likely aware of the big fish and they know there’s huge support below $3 right now.
Big fish buying long term but waiting for short term opportunities. They have about 3-4 weeks tops to get their fill.
Stock price doesn’t show that.... it does show shooting activity but that has subsided lately.
Yeah but then Greg got in Twitter and said they are no longer using 3rd party distribution. But then MedAir jumped on that and said that they are an authorized distributor.
Massive confusion on such a small point.
They need shareholder conference calls with Q&A.
Ok, sorry didn’t get the memo on that. Shhhh....
If the SP goes below .01 then Greg will release another PR to get the price up. Likely a copy of something he used before.
Kudos to NP on his aggression. Working with Mexico and the world will put back pressure on the USA to recognize people are unnecessarily dying waiting on compassionate use (similar to remdesivir recognition by FDA).
Remdesivir is NOT a viable standard of care, Fauci is wrong. Other countries should establish leronlimab as their standard of care and demonstrate reduced mortality.
It’s already in use and is the standard of care at our local hospitals. They know remdesivir and HCQ are ineffective.
The feds are way behind in terms of what works and doesn’t. That’s typically the case though.
Leronlimab isn’t mainstream here yet. I did give the info to our local hospitals but they are sticking to the plasma for now.
This board died quickly... Greg gave the P&D kids a run but couldn’t back up his PR claims with evidence I see... No one has a camera in Massachusetts? That’s odd.
When you say soon does that mean 2120? Asking for a friend
Appreciate the positivity. What is that positive outlook based on? Anything verifiable? The PR/Twitter accuracy needs a lot of work.
I’m sure if the company wanted to be transparent on current activities they could, just doesn’t seem like it’s a priority for the CEO.
Yeah, they’ll get it of their own accord. They’ll need trial sites etc.
To me this PR appears to be more bravado than substance at this timing, which is fine because that’s what’s needed. It tells the FDA they have confidence and aren’t afraid to prove it. It’s telling to the world ... if they are paying attention.
Agreed but some seem to think the latest PR will even the playing field... it doesn’t.
There’s nothing that says Gild has to participate. But I like NP’s call at the poker table. Great move by NP.
I’ve never seen this kind of aggression/transparency/confidence in the OTC.
I think that was my point
Beyond that... just general bigpharma shenanigans
Looks to me that BigPharm could just slow roll CytoDyn until ModeRNA gets vaccine done.
Kudos to NP to force the conversation.
Capn, Yep I can help with the OJ.
Thanks for keeping the OTC-OG honest. Anyway we can drag him by the ear to his pops? Lol.
Could be a great SS when they uplist and inst investors want a large chunk. Then the float will tighten up and the big boys get a free ride to the top.
It’s CaptnBob vs Greg right now and CaptnBob (et al) is whipping his ass in the public forum. VYST refuses to supply transparency like a proper pubco and the fins are always delayed.
I tune in every week just to see how The Capn will rip Greg’s ass a little more.
True, but gild won’t play fair
I see a hostile buyout attempt coming. Is NP in a position to withstand it?
Leronlimab in the hands of Gild would expedite production I’m sure.
I’m betting the Feds are pushing for this.
This needs to get to Chas Radovich
Yes, shareholders will have to start forcing these guys to act like a pubco
Thanks Bio... takes a village
They have to follow protocol. Some do better than others
Retail is useless... the commercial biz is where it’s at.
End of June at latest. FDA doesn’t like Americans dying on their watch. You could say things are expedited. Turn on the news.
Trial 2 is halfway full and 3 is still enrolling.
You mean other than her doctor not permitting her to take part in leronlimab trial? I told them to get a 2nd opinion, I hope they do.
If they truly have supply chain agreements for $1.362billion pending FDA approval I’m sure that would play into it.
Also, I’m sure NP knows much more about FDA status and funding than we do. All seem very confident right now.
The future exchange would love to have them before FDA approval hits.
Previous to Covid they did not meet the cash on hand requirements. I’d doubt they do now but the CEO says they do.
Time will tell if he’s right.
If leronlimab gets FDA approval for Covid it’ll likely get halted for 30 minutes and gap up quite a bit.
If they do uplist it’ll open up much more in terms of equity markets available.
I think that’s why the media can’t mention CytoDyn just yet, they have to keep it to monoclonal antitibodies.
I would hope they uplist before FDA approval
Company address of RXAir is same as Rotmans!
Let’s get to 5cents before close! Lol.
Bingo, maybe one day and with Covid revs that could be very soon.
I would find it rather funny that an OTC stock is taking the teeth out of the pandemic. A lot of retail exchanges won’t allow purchases of pinks unless a fiduciary responsibility waiver is signed.
The institutional investment % should go up quite a bit by end of year.
I don’t believe they meet the requirements for either Naz or NYSE. Sounds like hype.
MOA is too late for the symptom presentation. By the time they get admitted it’s about cytokine storm mitigation and not stopping viral replication. This is why Remdesivir also is non effective...
Given the dire need and the immediate MOA of leronlimab that would make sense.
Too many people dying in waiting